Some Factors Related to Refractive Errors in Students Aged 8–10 in Four Primary Schools in Hai Phong City, 2024
Journal of Health Sciences · 2025
DOI: 10.59070//jhs020624010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health Sciences, 2025. Verfasst von Duc Quan Nguyen und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To describe factors related to refractive errors in students aged 8–10 in four primary schools in Hai Phong City, 2024.
Methods
A cross-sectional descriptive study was conducted.
Results
The prevalence of refractive errors among students was 49.9%. Gender: Female students (OR: 1.3; 95% CI: 1.1–1.5, p < 0.05). Geography: Urban students (OR: 2.9; 95% CI: 2.5–3.4). Behavior: Students using computers (OR: 1.4; 95% CI: 1.2–1.7), screen time >1 hour/session (OR: 3.1; 95% CI: 2.2–4.5); TV viewing >1 hour/session (OR: 2.3; 95% CI: 1.9–2.8); electronic gaming (OR: 1.2; 95% CI: 1.01–2.4), gaming duration >1 hour/session (OR: 1.5; 95% CI: 1.2–2.0); reading >1 hour/session (OR: 1.5; 95% CI: 1.1–1.9). Family history: Students with a family history of refractive errors (OR: 1.8; 95% CI: 1.5–2.1). Parental knowledge: Parents with good knowledge about refractive errors (OR: 1.5; 95% CI: 1.2–1.9).
Zitieren
APA
Nguyen, D. Q., Le, H. S., Nguyen, T. P., & Nguyen, T. H. (2025). Some Factors Related to Refractive Errors in Students Aged 8–10 in Four Primary Schools in Hai Phong City, 2024. Journal of Health Sciences. https://doi.org/10.59070//jhs020624010
Vancouver
Nguyen DQ, Le HS, Nguyen TP, Nguyen TH. Some Factors Related to Refractive Errors in Students Aged 8–10 in Four Primary Schools in Hai Phong City, 2024. Journal of Health Sciences. 2025. doi:10.59070//jhs020624010
BibTeX
@article{Nguyen2025,
author = {Nguyen, Duc Quan and Le, Hong Son and Nguyen, Thi Phuong and Nguyen, Thi Hoa},
title = {Some Factors Related to Refractive Errors in Students Aged 8–10 in Four Primary Schools in Hai Phong City, 2024},
journal = {Journal of Health Sciences},
year = {2025},
doi = {10.59070//jhs020624010}
}
EUVIMED